A first for the Northwest, UW Cardiologist Creighton Don employed the AccuCinch device, a repair system system designed specifically to treat Mitral Regurgitation.
Behind the Procedure
In the small town of Twisp, Washington, Ed Ward went three weeks with little to no sleep in fear that he wouldn’t wake up after a diagnosis revealing symptoms of heart failure in 2017, with a the reading showing Functional Mitral Regurgitation (FMR). In the past, heart failure patients with FMR had but one solution via an intensive surgical procedure which most would not be able to be operated on. Luckily for Ward, our very own Cardiologist Creighton Don has been working on a clinical trial with Ancora Heart, a company with a groundbreaking device named AccuCinch.
The device aims to bring hope to patients by providing the world’s first Percutaneous Ventricular Repair (PVR) system designed to reduce FMR by repairing the left ventricle using a C-shaped device to repairing the left ventricle and slowing the progression of dilation in the left ventricle.
Right here at the UW Medical Center, one out of the only 18 locations worldwide currently offering the same procedure, Dr. Don placed the AccuCinch device in Ward on April 19th, and just two short days later, Ward was back up in Twisp. The procedure was the 25th ever done in the world, and the first in the Northwest region. With the trial hoping to reach 35 procedures, our Division of Cardiology will support Dr. Don in continuing trial the AccuCinch therapy. Dr. Don hopes the AccuCinch will be a permanent solution to Ward’s FMR, and provide as an innovative alternative to a rigorous surgical procedure.
Dr. Creighton Don
Dr. Don is an interventional cardiologist and a UW Assistant Professor of Medicine in the Division of Cardiology. He is experienced with percutaneous treatment for valvular heart disease, particularly transcatheter aortic valve replacement (TAVR), mitral balloon valvuloplasty, and transcatheter pulmonic valve replacement. He specializes in structural and congenital heart disease including catheter based treatment of atrial and ventricular septal defects, patent ductus arteriosus (PDA), paravaluvlar leaks, and coronary fistulae. He is also experienced in the management of acute coronary syndromes (heart attacks), percutaneous coronary interventions (coronary angioplasty and stenting), and chronic angina.